Update shared on04 Sep 2025
Despite an unchanged analyst price target for Docebo, the sharp rise in its future P/E ratio suggests heightened growth expectations are being offset by valuation concerns, resulting in no adjustment to its fair value at CA$55.02.
What's in the News
- Docebo provided earnings guidance for Q3 2025, expecting total revenue between $61.0 million and $61.2 million.
- Fiscal 2025 guidance calls for subscription revenue growth of 10.75% to 11.75% and total revenue growth of 10.0% to 11.0%.
- From April to May 2025, Docebo repurchased 1,174,365 shares (3.92%) for CAD 47.29 million, completing a total of 1,764,037 shares (5.86%) for CAD 71.82 million under the May 2024 buyback program.
- From May to June 2025, the company repurchased 867,187 shares (2.93%) for CAD 34.92 million, completing the buyback announced in May 2025.
Valuation Changes
Summary of Valuation Changes for Docebo
- The Consensus Analyst Price Target remained effectively unchanged, at CA$55.02.
- The Future P/E for Docebo has significantly risen from 23.68x to 32.77x.
- The Discount Rate for Docebo remained effectively unchanged, at 7.45%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.